PATUSKY CHRISTOPHER bought UTHR
April 24, 2026 · Form 4 insider transaction
PATUSKY CHRISTOPHER bought 2,910 shares of United Therapeutics Corporation at $101.80 per share, a transaction worth $296.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,910
Price
$101.80
Total value
$296.2K
InsiderPATUSKY CHRISTOPHER
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 24, 2026
Filing dateApril 24, 2026
Shares owned after4,400
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025.